DAVID LOWE

Profile

First Name

: DAVID

Middle Name

:

Last Name

: LOWE

Related Companies

Titles

Company Name

Related People

DIRECTOR

SEQUEL PHARMACEUTICALS INC

PAUL CHAMBERLAIN, STUART J.M. COLLINSON, HOWARD C. DITTRICH, BRIAN K. FARMER, NINA KJELLSON, MARK MURGERDITCHIAN, JOSEPH TURNER, DANIEL K. TURNER, III, ECKARD WEBER, RANDALL WOODS

DIRECTOR

CHARITY PARTNERS INC.

WILLIAM DAUGHERTY, STAN FEIG, JAMES GILBERT, JOEL KATZ, JOEL A. KATZ, ROBERT LIGHT, PHIL O-DONNELL, GEORGE OVERHOLSER, JORD W. POSTER, CAL RIPKEN, JR., FRED ROSEN, ANTHONY K. TJAN, TONY TJAN, MICHAEL VEYSEY, ROBERT WALDRON, JAY WHITEHEAD

EXECUTIVE OFFICER, DIRECTOR

AEGLEA BIOTHERAPEUTICS HOLDINGS, LLC

GEORGE GEORGIOU, ARMEN SHANAFELT, HENRY SKINNER, CHARLES YORK

DIRECTOR

AMARANTUS BIOSCIENCE HOLDINGS, INC.

MARK BENEDYK, DR. JOHN W COMMISSIONG, GERALD COMMISSIONG, GERALD E COMMISSIONG, JOHN COMMISSIONG, MARC FAERBER, MARC E FAERBER, ROBERT FARRELL, ROBERT HARRIS, ROBERT L HARRIS, DONALD HUFFMAN, IAIN ROSS, STEVEN SPENCE

EXECUTIVE OFFICER, PROMOTER

INSIGNIA CAPITAL PARTNERS II, L.P.

TONY BROGLIO, MEL DEANE

EXECUTIVE OFFICER, PROMOTER

INSIGNIA CAPITAL PARTNERS II-A, L.P.

TONY BROGLIO, MEL DEANE

Filings

Filing Date

Filing Type

Source URL

Industry Classifier

Detailed Industry

Revenue Range

Securities

First Sale Date

D/A

PRIVATE EQUITY FUND

DECLINE TO DISCLOSE

Equity

2021-05-19

D/A

PRIVATE EQUITY FUND

DECLINE TO DISCLOSE

Equity

2021-05-19

D/A

PRIVATE EQUITY FUND

DECLINE TO DISCLOSE

Equity

2021-05-19

D/A

PRIVATE EQUITY FUND

DECLINE TO DISCLOSE

Equity

2021-05-19

D

PHARMACEUTICALS

DECLINE TO DISCLOSE

Equity

2017-06-14

D

PHARMACEUTICALS

PHARMACEUTICAL PREPARATIONS [2834]

NO REVENUES

Equity

2014-11-07

D/A

BIOTECHNOLOGY

DECLINE TO DISCLOSE

Equity

2013-12-24

D

BIOTECHNOLOGY

DECLINE TO DISCLOSE

Equity

2013-12-24

D

OTHER

DECLINE TO DISCLOSE

Equity, Debt

2010-11-29

D

PHARMACEUTICALS

DECLINE TO DISCLOSE

Debt

2010-08-30

D

PHARMACEUTICALS

DECLINE TO DISCLOSE

Debt

2009-08-03